CHRNA7 and non-small cell lung carcinoma: Furthermore, an α7 nAChR-dependent activation of the MEK/ERK signaling pathway was found to play a role in non-small cell lung cancer progression, especially during epithelial–mesenchymal transition, in tumor growth, and in vimentin expression [86,87].